ArticleCancer genomics & proteomics

Evaluating the Impacts of CYP3A4*1B and CYP3A5*3 Variations on Pharmacokinetic Behavior and Clinical Outcomes in Multiple Myeloma Patients With Autologous Stem Cell Transplant.

Junan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.